About Affymax (OTCMKTS:AFFY)
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
SymbolOTCMKTS:AFFY
CUSIP00826A10
Phone650-812-8700
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares37,490,000
Affymax (OTCMKTS:AFFY) Frequently Asked Questions
What is Affymax's stock symbol?
Affymax trades on the OTCMKTS under the ticker symbol "AFFY."
Who are some of Affymax's key competitors?
Some companies that are related to Affymax include Global Future City (FTCY), Myrexis (MYRX), Propanc Biopharma (PPCB), Aeolus Pharmaceuticals (AOLS), FutureWorld (FWDG), TetraLogic (TLOG), Pivotal Therapeutics (PVTTF), HST Global (HSTC), Targeted Medical Pharma (TRGM), Tianyin Pharmaceutical (TPIY), Inspyr Therapeutics (NSPX), EPIRUS Biopharmaceuticals (EPRSQ), Poniard Pharmaecuticals (PARD), American Oriental (AOBI) and Bohai Pharmaceuticals Group (BOPH).
Who are Affymax's key executives?
Affymax's management team includes the folowing people:
- Mr. Mark G. Thompson, Chief Financial Officer and Sec. (Age 56)
- Mr. Jonathan M. Couchman CFA, Chief Exec. Officer, Pres and Director (Age 48)
- Dr. Tracy J. Dunn Ph.D., J.D., VP of Intellectual Property & Legal Affairs (Age 55)
- Ms. Kay Slocum, Sr. VP of HR (Age 71)
Has Affymax been receiving favorable news coverage?
Media headlines about AFFY stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Affymax earned a coverage optimism score of 0.20 on Accern's scale. They also assigned news coverage about the biopharmaceutical company an impact score of 47.26 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of Affymax?
Shares of AFFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymax's stock price today?
One share of AFFY stock can currently be purchased for approximately $0.0125.
How big of a company is Affymax?
Affymax has a market capitalization of $510,000.00.
How can I contact Affymax?
Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]
MarketBeat Community Rating for Affymax (AFFY)
MarketBeat's community ratings are surveys of what our community members think about Affymax and other stocks. Vote "Outperform" if you believe AFFY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Affymax (OTCMKTS:AFFY) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 4/24/2016 forward)
Affymax (OTCMKTS:AFFY) Earnings History and Estimates Chart
Affymax (OTCMKTS AFFY) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/31/2014 | Q2 2014 | | $0.19 | | $0.04 million | View | N/A |  |
| 5/6/2014 | Q1 2014 | | ($0.04) | | | View | N/A | |
| 3/31/2014 | Q4 2013 | | ($0.03) | | | View | N/A | |
| 11/5/2013 | Q3 2013 | | ($0.05) | | | View | N/A | |
| 8/5/2013 | Q2 2013 | | $0.12 | | $0.53 million | View | N/A | |
| 5/9/2013 | Q113 | ($0.66) | ($0.71) | $63.20 million | $0.8390 million | View | N/A | |
| 4/2/2013 | Q4 2012 | ($0.61) | ($1.85) | $14.81 million | $14.77 million | View | N/A | |
| 11/8/2012 | Q312 | ($0.70) | ($0.68) | $13.41 million | $13.60 million | View | N/A | |
| 8/8/2012 | | ($0.67) | ($0.89) | | | View | N/A | |
| 5/7/2012 | Q1 2012 | $0.50 | $0.87 | | | View | N/A | |
| 3/14/2012 | Q4 2011 | ($0.62) | ($0.86) | | | View | N/A | |
| 11/9/2011 | Q3 2011 | ($0.35) | ($0.28) | | | View | N/A | |
| 8/8/2011 | Q2 2011 | ($0.61) | ($0.35) | | | View | N/A | |
| 5/9/2011 | Q1 2011 | ($0.69) | ($0.36) | | | View | N/A | |
| 3/10/2011 | Q4 2010 | ($0.56) | ($0.46) | | | View | N/A | |
| 11/5/2010 | Q3 2010 | ($0.29) | ($0.49) | | | View | N/A | |
| 8/4/2010 | Q2 2010 | $0.48 | $0.70 | | | View | N/A | |
| 5/6/2010 | Q1 2010 | ($0.36) | ($0.33) | | | View | N/A | |
| 3/4/2010 | Q4 2009 | ($1.15) | ($0.63) | | | View | N/A | |
| 11/4/2009 | Q3 2009 | ($1.24) | ($0.97) | | | View | N/A | |
| 8/5/2009 | Q2 2009 | ($1.24) | ($1.17) | | | View | N/A | |
| 5/7/2009 | Q1 2009 | ($1.46) | ($1.32) | | | View | N/A | |
| 3/12/2009 | Q4 2008 | ($1.54) | ($1.68) | | | View | N/A | |
| 11/6/2008 | Q3 2008 | ($1.30) | ($1.72) | | | View | N/A | |
| 8/18/2008 | Q2 2008 | ($1.23) | ($1.24) | | | View | N/A | |
| 5/9/2008 | Q1 2008 | ($0.95) | ($1.03) | | | View | N/A | |
| 3/13/2008 | Q4 2007 | ($0.94) | ($0.92) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Affymax (OTCMKTS:AFFY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Affymax (OTCMKTS AFFY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.55%
Affymax (OTCMKTS AFFY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/28/2013 | John Peter Walker | Director | Sell | 16,540 | $1.92 | $31,756.80 | | |
(Data available from 1/1/2013 forward)
Affymax (OTCMKTS AFFY) News Headlines
| Source: |
|
Affymax (OTCMKTS:AFFY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Affymax (OTCMKTS:AFFY) Income Statement, Balance Sheet and Cash Flow Statement
Affymax (OTCMKTS AFFY) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
